PROTECT-TIMI 30 Trial

NCT00250471 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
900
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Millennium Pharmaceuticals, Inc.